Oxytocin, which has “shown promise as a novel antipsychotic in multiple clinical trials,” improved cognition in a small sample (n=15) of people with schizophrenia diagnoses. Results appear online today in Schizophrenia Research.
Feifel, D; MacDonald, K; Cobb, P; Arpi, M; “Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.” Schizophrenia Research, online June 8, 2012.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.
Sorry guys, Celine Dion knew it before you did.
Oxytocin is the peptide that rushes through some animals (humans and prairie voles are two) when, for example, we snuggle our newborns.
Can we first try to include our distressed friends and family members more generously into the circle of our communities instead of seeking and pushing yet another expensive treatment? Another expensive treatment with dangerous side effects that we will then force on folks, while they suffer in isolation, often in locked rooms?
Are we seriously considering trusting and further enriching the companies that brought us neuroleptics to sell us oxytocin nasal spray as the next magic bullet that will keep our kids and us smiling and still?